Analyst Research
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: Wright Reports
|
$460.00
|
|
Provider: Wright Reports
|
$127.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
GL Sciences Inc. Amends Full-year Consolidated Outlook for FY Ended March 31, 2012
GL Sciences Inc. announced that it has lowered its full-year consolidated outlook for revenue from JPY 17,257 million to JPY 16,510 million, but raised its full-year consolidated outlook for operating profit from JPY 805 million to JPY 939 million, ordinary profit from JPY 757 million to JPY 962 million, net profit from JPY 438 million to JPY 610 million and earning per share from JPY 85.45 to JPY 118.96 for the fiscal year ended March 31, 2012. The Company lowered its full-year outlook mainly due to the business recovery of subsidiaries of the Company.
Latest Key Developments in Office
- Sequana SA's Antalis Makes Binding Offer To Acquire Xerox Corp's Western European Paper Business
- Aurora Corp Appoints New Chairman of the Board
- PSI Group ASA Sells Its InStore IT Shares to Visma for NOK 49.8 Million; Companies to Continue Cooperation
- Levenguk OAO Declares No FY 2012 Dividend Payment; Appoints Auditor-SKRIN
- Share this
- Link this
- Digg this
Follow Reuters